Y. Xin
机构：Shanghai Medical Information Center
发表论文 3 篇 · 总被引 13 次 · h-index 2
代表论文
- 423P Fruquintinib plus sintilimab in refractory repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Preliminary clinical results and biomarker analyses from a phase II study (2022 · Annals of Oncology · 被引 9)
- Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR/MSS refractory metastatic colorectal cancer: a phase 2 clinical trial (2025 · Cancer Immunology Immunotherapy · 被引 3)
- List of contributors (2015 · Elsevier eBooks)